The goal of this pilot project was to assess the presence of a number of commonly prescribed human use pharmaceuticals in three coastal areas of the U.S. Water samples were collected in conjunction with three NOAA monitoring/research projects to assess sediment contamination, macrobenthic infaunal communities, and bioeffects in the Chesapeake Bay, Biscayne Bay, and the Gulf of the Farallones.
DATA/REPORT DETAILS
Human Use Pharmaceuticals in the Estuarine Environments: A Survey in the Chesapeake and Biscayne Bays
- Published on:
- Science Area(s): Biological Effects of Contaminants and Nutrients, Stressor Impacts and Mitigation
- Region(s) of Study: Atlantic Ocean, California, Chesapeake Bay, Florida, Pacific Ocean, U.S. States and Territories, Waterbodies
- Primary Contact(s): tony.pait@noaa.gov
Citation:
Pait, A.S., R.A. Warner, S.I. Hartwell, J.O. Nelson, P.A. Pacheco, and A. Mason
Pait, A.S., R.A. Warner, S.I. Hartwell, J.O. Nelson, P.A. Pacheco, and A. Mason
Data/Report Type:
NOAA Technical Memorandum
NOAA Technical Memorandum
Description
Note to readers with disabilities: Some scientific publications linked from this website may not conform to Section 508 accessibility standards due to the complexity of the information being presented. If you need assistance accessing this electronic content, please contact the lead/corresponding author, Primary Contact, or nccos.webcontent@noaa.gov.